Navigation Links
Additional Clinical Trial to be Conducted for KYNAPID Under FDA Special Protocol Agreement
Date:8/10/2009

    NASDAQ: CRME   TSX: COM

VANCOUVER and DEERFIELD, IL, Aug. 10 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. (NASDAQ: CRME/TSX: COM) and its co-development partner Astellas Pharma US, Inc. ("Astellas") announced today that Astellas will undertake a single confirmatory additional Phase 3 clinical trial of KYNAPID(TM) (vernakalant hydrochloride) Injection for rapid conversion of atrial fibrillation to sinus rhythm. The trial, to be called ACT 5, is expected to begin enrolling patients by the end of 2009, with completion expected in the first half of 2011.

The decision to conduct another trial was reached following extended discussions with the FDA to define the best regulatory path forward for KYNAPID. Under the Special Protocol Assessment (SPA) process, the FDA has agreed that the design and planned analysis of the study adequately address objectives in support of the KYNAPID New Drug Application (NDA). The prospectively-defined trial will enroll recent-onset atrial fibrillation patients without a history of heart failure. Cardiome and Astellas believe that this study, coupled with the overall clinical development program, should in principle meet the FDA standards for approval.

"In addition to receiving a positive recommendation for approval from the FDA Cardiovascular and Renal Drugs Advisory Committee, KYNAPID has demonstrated consistent results across all of the four completed Phase 3 clinical trials," said William E. Fitzsimmons, PharmD, Senior Vice President, Development at Astellas. "We are confident that the ACT 5 trial will confirm these prior results and further demonstrate the therapeutic value of this exciting drug candidate."

"We support the decision to conduct the ACT 5 trial, and we will assist our partner Astellas in every way to expedite the launch and successful completion of this study," said Doug Janzen, President and Chief Executive Officer of Cardiome. "We estimate that Cardiome's alloca
'/>"/>

SOURCE Cardiome Pharma Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. aTyr Pharma Raises an Additional $12 Million
2. Texas Kidney Community: CMS Authorization to Survey 22 New Dialysis Centers Excellent First Step Toward Opening Additional Pending Facilities, Creating More Local Jobs
3. SETO Holdings, Inc. Enters Into Two Additional Leases for Two New Hearing Centers in Maryland and Virginia
4. Mylan Receives FDA Approval for Additional Strengths of the Antipsychotic Haloperidol
5. For Treatment of Type 2 Diabetes, 89 Percent of Surveyed Endocrinologists Identify a Need for Additional GLP-1 Analogues and 71 Percent Say the Same About DPP-IV Inhibitors
6. Specialty Hospitals of Washington Adds Additional Skilled Nursing Facility Beds at United Medical Center in South East DC
7. King Provides Additional Information on the REMOXY(R) NDA Resubmission Plan
8. Visit to the doctor: The supply of additional private services is increasing
9. Business, Health Care Leaders Call on Texas Employers to Cover Smoking Cessation Benefits for an Additional 100,000 People by 2010
10. Mylan Receives FDA Approval for Additional Strength of Generic Restoril(R)
11. New Jersey University Hospital to Pay Additional $2 Million to Resolve Fraud Claims That Facility Double Billed Medicaid
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2015)... 2015 Barbara Crone has joined Women’s Excellence ... being of the men, women and families who seek her care, ... care for families in the home. , “When ... wondering if I could complete their care with the delivery of ... my mentor Nurse Midwife, I knew it was time for me ...
(Date:5/3/2015)... VEGAS and LOS ANGELES, American Telemedicine Association 2015 ... vitaphone e-health solutions, a full-service telemedicine ... launch of its new platform, VITA health services ... The VITA health services platform enables remote patient ... such as congestive heart failure (CHF), diabetes, COPD, ...
(Date:5/3/2015)... " Bubbly Walrus ” was featured on NewsWatch as ... the latest and coolest applications on the market for iOS, ... technology expert, conducted the app review and shared with viewers ... best games to play on smartphones are the ones that ... cells with a video game that just absorbs attention, why ...
(Date:5/3/2015)... ” was featured on NewsWatch as part of its monthly ... available to consumers. Scott Steinberg, a technology expert and special ... how to protect their private information. , A lot of ... more so online. It helps everyone stay connected with friends ... terms of work, the internet makes things more efficient. But ...
(Date:5/3/2015)... 03, 2015 NuevaCare announced today that ... upcoming area seminars. The first event will take place ... Stroke Conference to be held at The Magnolia of ... May 13 during the Dementia Conference to be held ... seminars offer an excellent opportunity to learn about the ...
Breaking Medicine News(10 mins):Health News:Women's Excellence In Midwifery Welcomes Barbara Crone 2Health News:vitaphone e-health solutions U.S. Announces VITA Health Services for Remote Chronic Disease Management 2Health News:vitaphone e-health solutions U.S. Announces VITA Health Services for Remote Chronic Disease Management 3Health News:An Application to Have Fun with Mathematics Was Featured on NewsWatch Television 2Health News:A Method to Keep Private Information Secure was Featured on NewsWatch Television 2Health News:NuevaCare Introduces MnemeTherapy® Approach to Care for Elderly Patients with Alzheimer’s, Stroke and Other Types of Neurodegenerative Conditions 2
... Early Results Show Customers Already Breaking down Silos ... BRIDGEWATER, N.J., March 5 Waters Corporation (NYSE: ... today jointly announced a strategic partnership to integrate ... laboratory dependent organizations. Collaborating with existing common ...
... 5 A new analysis by Avalere Health found ... out-of-pocket -- a full 10% higher than amounts reported ... do not include spending on assisted living, a key ... the California-based SCAN Foundation, found that individuals and their ...
... Biomedical Informatics Market Leader BioFortis wins another ... by leading pharmaceutical and institutional clients worldwide ... clinical researchCOLUMBIA, Md., March 5 /PRNewswire/ ... of biomedical informatics solutions used by pharmaceutical ...
... Go Back to the Basics: Healthy Living Web Source Offers ... a Luxury Resort & Spa ExperienceWESTCHESTER, Ill., March 5 ... New Year,s resolutions fall off the wagon by Valentine,s Day(1). ... such lofty expectations in the first place? Old London, ...
... The new medical subspecialty of Advanced Heart Failure and ... advanced yet cost-effective care for patients with heart failure, ... the Journal of Cardiac Failure ( www.onlinejcf.com ... America (HFSA) and the Japanese Heart Failure Society, published ...
... NEW YORK, March 5 HMS Holdings Corp. ... for government healthcare programs, today announced the promotions ... Christina Dragonetti to Executive Vice President, Commercial Markets; ... Markets. These promotions follow the company,s announcement on ...
Cached Medicine News:Health News:Waters and LabVantage Partnership Targets Laboratory Informatics Integration to Maximize Data Management and Quality of Work 2Health News:Waters and LabVantage Partnership Targets Laboratory Informatics Integration to Maximize Data Management and Quality of Work 3Health News:Waters and LabVantage Partnership Targets Laboratory Informatics Integration to Maximize Data Management and Quality of Work 4Health News:Almost 30% of Long-Term Care is Financed Out-of-Pocket, Report Finds 2Health News:BioFortis Wins Best Product Award in Discovery Informatics at the 2009 Molecular Medicine Tri-Conference 2Health News:Samantha Harris Launches 'A Toast for Everyday Health' 2Health News:Samantha Harris Launches 'A Toast for Everyday Health' 3Health News:Samantha Harris Launches 'A Toast for Everyday Health' 4Health News:New specialty to focus on advanced heart failure and heart transplantation 2Health News:HMS Holdings Corp. Announces Executive Promotions 2
(Date:5/4/2015)... Tenn. , May 4, 2015  Verus Healthcare, ... its acquisition of CPAP Care Club in 2012.  Since ... business within the durable medical equipment (DME) industry by ... patients for their CPAP supply needs and processes nearly ... bought this company three years ago, the systems and ...
(Date:5/4/2015)... Medical Services Holdings Limited ("CCM" or the "Company") (NYSE: ... operator of the largest network of radiotherapy and diagnostic imaging ... an Extraordinary General Meeting ("EGM") will be held on May ... time) at CCM,s office at 18/F, Tower A, Global Trade ... Beijing, P.R. China . Only shareholders ...
(Date:5/4/2015)... , May 4, 2015   Synthetic Biologics, ... therapeutics focused on protecting the microbiome, as well as ... has been appointed Chief Financial Officer, Treasurer and Secretary ... Ballantyne who will be leaving the Company in ... brings to Synthetic Biologics operational, financial and international biotech ...
Breaking Medicine Technology:Verus Healthcare Celebrates 1,000% Growth on Third Anniversary 2Concord Medical Services Announces 2015 Extraordinary General Meeting of Shareholders 2Steven Shallcross Named Chief Financial Officer of Synthetic Biologics 2Steven Shallcross Named Chief Financial Officer of Synthetic Biologics 3
... BD (Becton, Dickinson and Company) (NYSE: BDX ... revenues of $2.051 billion for the fourth fiscal quarter ended ... the prior-year period, or 4.0 percent on a foreign currency-neutral ... September 30, 2011, BD reported revenues of $7.829 billion, representing ...
... NEW YORK, Nov. 1, 2011 Keryx Biopharmaceuticals, Inc. ... on the acquisition, development and commercialization of medically important ... disease, today announced that a conference call will be ... EDT to discuss results for the third quarter ended ...
Cached Medicine Technology:BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 2BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 3BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 4BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 5BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 6BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 7BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 8BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 9BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 10BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 11BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 12BD Announces Results for 2011 Fourth Fiscal Quarter and Full Year 13Keryx Biopharmaceuticals, Inc. to Host Conference Call on Third Quarter 2011 Financial Results 2
... a comprehensive set of guidelines to ... systems (SDS) reagents and instrumentation. These ... follow. Many traditional variables, such as ... cycling protocol itself, have been standardized, ...
ThermalSeal RT (5mil) is Optically Clear for Real Time PCR and easy to apply. Works for all plates. Will not wrinkle in the freezer....
Sealing tape featuring 3M adhesive technology. Repeat piercing with minimal residue. Not recommended for DMSO. Non-tacky to skin and gloves....
Sealing tape, slightly stiffer than Polyolefin tape. Certified RNase and DNase free....
Medicine Products: